These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11116143)
1. Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity. Fawcett J; Hamel FG; Bennett RG; Vajo Z; Duckworth WC J Biol Chem; 2001 Apr; 276(15):11552-8. PubMed ID: 11116143 [TBL] [Abstract][Full Text] [Related]
2. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120 [TBL] [Abstract][Full Text] [Related]
3. Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin. Hamel FG; Siford GL; Fawcett J; Chance RE; Frank BH; Duckworth WC Metabolism; 1999 May; 48(5):611-7. PubMed ID: 10337862 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the inhibition of protein degradation by insulin in L6 cells. Fawcett J; Hamel FG; Duckworth WC Arch Biochem Biophys; 2001 Jan; 385(2):357-63. PubMed ID: 11368017 [TBL] [Abstract][Full Text] [Related]
5. Use of high affinity insulin analogues to assess the functional relationships between insulin receptor trafficking, mitogenic signaling and mRNA expression in rat liver. Authier F; Merlen C; Amessou M; Danielsen GM Biochimie; 2004 Mar; 86(3):157-66. PubMed ID: 15134829 [TBL] [Abstract][Full Text] [Related]
6. Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors. Hennige AM; Strack V; Metzinger E; Seipke G; Häring HU; Kellerer M Diabetologia; 2005 Sep; 48(9):1891-7. PubMed ID: 16052329 [TBL] [Abstract][Full Text] [Related]
7. Effect of the insulin analogue [LYS(B28),PRO(B29)] on blood glucose control. Trautmann ME Horm Metab Res; 1994 Dec; 26(12):588-90. PubMed ID: 7705764 [TBL] [Abstract][Full Text] [Related]
8. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Bornfeldt KE; Gidlöf RA; Wasteson A; Lake M; Skottner A; Arnqvist HJ Diabetologia; 1991 May; 34(5):307-13. PubMed ID: 1713869 [TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues. Glendorf T; Knudsen L; Stidsen CE; Hansen BF; Hegelund AC; Sørensen AR; Nishimura E; Kjeldsen T PLoS One; 2012; 7(2):e29198. PubMed ID: 22383948 [TBL] [Abstract][Full Text] [Related]
10. Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase. Authier F; Danielsen GM; Kouach M; Briand G; Chauvet G Endocrinology; 2001 Jan; 142(1):276-89. PubMed ID: 11145591 [TBL] [Abstract][Full Text] [Related]
11. Preparation of a microcrystalline suspension formulation of Lys(B28)Pro(B29)-human insulin with ultralente properties. Richards JP; Stickelmeyer MP; Frank BH; Pye S; Barbeau M; Radziuk J; Smith GD; DeFelippis MR J Pharm Sci; 1999 Sep; 88(9):861-7. PubMed ID: 10479347 [TBL] [Abstract][Full Text] [Related]
12. Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Hofmann C; Marsh JW; Miller B; Steiner DF Diabetes; 1980 Nov; 29(11):865-74. PubMed ID: 7000584 [TBL] [Abstract][Full Text] [Related]
13. Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study. Birnbaum DT; Kilcomons MA; DeFelippis MR; Beals JM Pharm Res; 1997 Jan; 14(1):25-36. PubMed ID: 9034217 [TBL] [Abstract][Full Text] [Related]
14. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells. Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490 [TBL] [Abstract][Full Text] [Related]
15. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Howey DC; Bowsher RR; Brunelle RL; Woodworth JR Diabetes; 1994 Mar; 43(3):396-402. PubMed ID: 8314011 [TBL] [Abstract][Full Text] [Related]
17. The relationship between insulin binding and the inhibition of protein degradation in normal and transformed cells. Ballard FJ; Gunn JM Horm Metab Res; 1980 Jan; 12(1):10-4. PubMed ID: 6987137 [TBL] [Abstract][Full Text] [Related]
18. Insulin inhibition of protein degradation in cell monolayers. Ballard FJ; Wong SS; Knowles SE; Partridge NC; Martin TJ; Wood CM; Gunn JM J Cell Physiol; 1980 Nov; 105(2):335-46. PubMed ID: 7007398 [TBL] [Abstract][Full Text] [Related]
19. Mode of uptake and degradation of 125I-labelled insulin by isolated hepatocytes and H4 hepatoma cells. Terris S; Hofmann C; Steiner DF Can J Biochem; 1979 Jun; 57(6):459-68. PubMed ID: 476501 [TBL] [Abstract][Full Text] [Related]
20. Insulin rapidly inhibits insulin-like growth factor-binding protein-1 gene expression in H4-II-E rat hepatoma cells. Orlowski CC; Ooi GT; Brown DR; Yang YW; Tseng LY; Rechler MM Mol Endocrinol; 1991 Aug; 5(8):1180-7. PubMed ID: 1719386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]